Silexion Therapeutics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 26, 2026, 4:05 p.m. ETView on SEC.gov Our explainer
Amendments to articles or bylaws; fiscal year change · Submission of matters to a vote of security holders · Financial statements and exhibits
AI summary, unreviewedSilexion Therapeutics Approves Authorized Share Capital Increase to 515.9 Million Shares and 1-for-24 Reverse Split
8-KSept. 30, 2026, 8:52 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KSept. 29, 2026, 10:31 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Unregistered sales of equity securities · Other events · Financial statements and exhibits
8-KSept. 28, 2026, 8:46 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KSept. 25, 2026, 4:15 p.m. ETView on SEC.gov
Delisting notice / failure to meet listing standard
8-KSept. 25, 2026, 4:05 p.m. ETView on SEC.gov
Submission of matters to a vote of security holders
8-KAug. 21, 2026, 4:21 p.m. ETView on SEC.gov
Delisting notice / failure to meet listing standard
8-KAug. 14, 2026, 9 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
8-KAug. 13, 2026, 5:06 p.m. ETView on SEC.gov
Other events · Financial statements and exhibits
8-KAug. 13, 2026, 4:02 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Other events · Financial statements and exhibits
8-KAug. 10, 2026, 6:16 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KAug. 4, 2026, 4:10 p.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KAug. 3, 2026, 9:28 a.m. ETView on SEC.gov
Other events
8-KJuly 31, 2026, 4:06 p.m. ETView on SEC.gov
Departure/appointment of directors or officers
8-KJuly 29, 2026, 4:05 p.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits